Paresh Dandona MD, PhD

Paresh Dandona

Paresh Dandona
MD, PhD

SUNY Distinguished Professor

Department of Medicine

Jacobs School of Medicine & Biomedical Sciences


Specialty/Research Focus

Endocrinology; Endocrinology; Endocrinology, Diabetes and Metabolism

Contact Information
1020 Youngs Road
Williamsville, New York 14221
Phone: (716) 961-9900
Fax: (716) 961-9911
dandona@buffalo.edu


Patient Care

This faculty member is affiliated with UBMD, practicing physicians who are also professors in the Jacobs School.

View this physician on UBMD


Professional Summary:

Vascular cell reactivity encompassing platelet function, endothelial function, monocyte/macrophage function and the interactions between them (adhesion molecules viz lCAM, VCAM, P-selectin, L-selectin, E-selectin, etc.). Reactive Oxygen Species (ROS) in diabetes, atherosclerosis, hypertension, aging, infection, etc. and a consequential damage to
lipids, proteins and DNA. Regulation of aromatase, the effect of estrogen on estrogen receptor, androgen receptor and glucocortico receptor (elucidationi of pre- and post-receptor mechanisms in menopause, etc.). Venous reactivity with measurements of venous diameter and flow velocity and the effect of various drugs in NIDDM, IDDM, and IGT. Genetic regulation of aromatase and estrogen receptor. The role of nitric oxide in vascular reactivity, vis-a-vis various complications of diabetes and other factors involved with vascular reactivity. Effects of endotoxin on adhesion molecules, PAF, platelets, ROS and procalcitonin.

Education and Training:

  • Fellowship, American College of Endocrinology (2004)
  • Fellowship, American College of Cardiology (1996)
  • Fellowship, American College of Physicians (1995)
  • Fellowship, Royal College of Physicians (U.K.) (1988)
  • PhD, Oxford University (1975)
  • Medicine, All India Institute of Medical Sciences (1965)
  • BS, Chemistry, Allahabad University (1960)

Employment:

  • SUNY Distinguished Professor, Medicine, University at BUffalo Jacobs School of Medicine & Biomedical Sciences (2011-present)
  • Professor, University at Buffalo Jacobs School of Medicine & Biomedical Sciences (1996-present)
  • Founder & Medical Director, Diabetes-Endocrinology Center of Western New York (1995-present)
  • Professor, Medicine, University at Buffalo (1991-present)
  • Ex Chief of Endocrinology, Internal Med Endocrinology, University at Buffalo Kaleida Health UBMD (1991–2018)

Awards and Honors:

  • Pharmacia- Pfizer Award (2002)
  • Valor Award (2001)
  • Distinguished Service Award (2001)
  • Madhav Award (1997)
  • Alert Award (1996)
  • Distinguished Service Award (1993)
  • Rhodes Scholarship (1966)

Research Centers:

  • Diabetes-Endocrinology Center of Western New York

UB 2020 Strategic Strengths:

  • Health and Wellness Across the Lifespan

Grants and Sponsored Research:

  • December 2012–November 2014
    Anti-Diabetic Effects of Liraglutide in Adolescents and Young Subjects with Type 1 Diabetes
    American Diabetes Association
    Role: Principal Investigator
    $600,000

Journal Articles:

See all (458 more)

Abstracts:

  • Al-Ghazi MN, Ciancio SG, AlJada A, Bessinger M, Mather M, Mohanty P, Dandona P. (2003) Evaluation of Efficacy of Administration of Sub-antimicrobial-dose Doxycycline in the Treatment of Generalized Adult Periodontitis in Diabetics. J Dent Res, (Mar)
  • Tripathy, D., Dhindsa S, Aljada, A., Hofmeyer, D., Syed, T., Dandona P. (2003) Acute elevation of plasma free fatty acids (FFA) increases the macrophage migration inhibitory factor (MIF) in healthy subjects. Diabetes, (Jan) A180
  • Aljada, A., Ghanim, H., Mohanty, P., Dhindsa S, Bandyopadhyay, A., Dandona P. (2003) Plasma homocysteine concentrations are elevated in the obese and in males: Absence of an effect by thiazolidinediones. Endocrine Society, (Jan) P3-473
  • Ciancio SG, Aljada A, Mohanty P, Ross C, Dandona P. (2002) Comparative evaluation of adjunctive oral irrigation in diabetics. J Clin Periodontol, (Apr) 295-300
  • Mohanty, P., Aljada, A., Ghanim, H., Hofmeyer, D., Tripathy, D., Syed, T., Dhindsa S, Dandona P. (2002) Evidence for a potent anti-inflammatory effect of rosiglitazone in obese diabetic patients. Diabetes, (Jan) 408
  • Mohanty, P., Aljada, A., Ghanim, H., Hofmeyer, D., Tripathy, D., Syed, T., Dhindsa S, Dandona P. (2002) Evidence for a potent anti-inflammatory of rosiglitazone in obese diabetic patients. Endocrine Society, (Jan) 408
  • Tripathy, S., Dhindsa S, Garg, R., Dandona P. (2002) Hypgondotropic hypogonadism in erectile dysfunction associated with Type 2 diabetes mellitus: A common defect?. Endocrine Practice, (Jan) 145
  • Ciancio SG, Aljada A, Awa H, Hamouda W, Ghanim H, Zambon JJ, Dandona P, Boardman T, Ross C. (2001) Comparative evaluation of an adjunctive oral irrigation in diabetics. J Dent Res, (Jan)
  • Ciancio SG, Dandona P, Hamouda W, Ho A. (2000) Effect of irrigation on periodontal and metabolic parameters in diabetics. J Dent Res, (Jan)
  • Ciancio SG, Al-Suwyed A, Hamouda W, Dandona P. (1998) Free radical generation in patients with periodontal disease. J Dent Res, (Jan)
  • Waz WR, Dandona P, Love J, Bofinger DP, Van Liew JB, Feld LG. (1994) Nitric Oxide Production Increases in Post-Ischemic Rat Kidneys. J Am Soc Nephrol, (Jan) 912-912
  • Dandona P, Waz WR, Love J, Van Liew JB, Feld LG. (1994) Renal Cortical and Medullary Nitric Oxide Activity in Diabetic Rats. J Am Soc Nephrol, (Jan) 962-962
See all (2 more)

Professional Memberships:

  • American Diabetes Association; President-elect
  • American Heart Association; Member
  • Endocrine Society; Member
  • European Association for the Study of Diabetes; Member
  • International Diabetes Federation; Member
  • International Society for Hypertension in Blacks; Member
  • The North American Menopause Society; Member
  • American Association of Clinical Endocrinologists; Member
  • American College of Cardiology; Member

Presentations:

  • "Keynote lecture to the Korean Society for Free Radical Biology" (2009)
  • "As a Global Eminent Scholar" ; Kyung Hee University (2009)
  • "Lecture on hypogonadotrophic hypogonadism in type 2 diabetes and the relevance to cardiovascular disease at the Vascular biology Working Group Meeting" American Heart Association; American Heart Association (2009)
  • "Lecture on the anti-inflammatory and cardio-protective effects of insulin at the NATURE-MEDICINE Symposium on Metabolic Disease" (2009)
  • "Metabolic and Cardiovascular Disease Review Hearing" (2009)
  • "Presentation on the anti-inflammatory and cardio-protective effects of insulin" (2009)
  • "Presentations at the International Diabetes Federation Conference" (2009)
  • "Talk at US National Diabetes Advisory Board Meeting with Sanofi Aventis" (2009)
  • "inflammation, insulin and glucose" ; Children’s Hospital (2009)
  • "lecture on insulin, glucose an inflammation" ; Brigham and Women’s Hospital, Harvard University in Boston (2009)
  • "Lecture on Thiazolidenediones" (2009)
  • "Lectures at Pan Arab Congress of Endocrinology" (2009)
  • "the anti-inflammatory effects of insulin" eystone conference; eystone conference (2009)
  • "AACE Satellite Symposium and lecture on obesity and inflammation" ; AACE (2009)
  • "Keynote lecture to the Pan-Arab Endocrine Societies" (2009)
  • "NIH Workshop on Inflammation and Metabolic Disease" ; NIH (2009)
  • "Diabetes National Alliance Meeting and Lecture" (2009)
  • "Diabetes Symposium" Kyung Hee University Hospital; Kyung Hee University Hospital (2009)
  • "Euro Web Conference and Lecture on insulin and diabetic control" (2009)
  • "symposium onWelchol" (2009)
  • "VA Grand Rounds" (2009)
  • "Vascular Biology Working Group lecture on glycemia and cardiovascular syndromes" (2009)
  • "Grand Rounds at ECMC" ; ECMC (2009)
  • "insulin and diabetes" (2009)
  • "Lecture on Diabetes" ; Tulane University (2009)
  • "Seminar on Insulin as an anti-inflammatory and atherogenesis modulator" (2009)
  • "Vascular biology working group talk on glycemia, insulin and cardiovascular syndrome" American College of Cardiology; American College of Cardiology; American College of Cardiology (2009)
  • "Aggressive treatment of Diabetes" Aggressive treatment of Diabetes (2009)
  • "Coreg Panel Discussion Speaker Teleconference" Coreg Panel Discussion Speaker Teleconference; Coreg Panel Discussion Speaker Teleconference; Coreg Panel Discussion Speaker Teleconference (2009)
  • "Coreg Speaker Meeting" Coreg Speaker Meeting; ; Coreg Speaker Meeting (2009)
  • "National Diabetes Alliance Meeting" National Diabetes Alliance Meeting; ; National Diabetes Alliance Meeting (2009)
  • "Novo Nordisk Liraglutide Development Meeting" Novo Nordisk; Novo Nordisk (2009)
  • "Lecture National Diabetes Alliance Meeting" Lecture National Diabetes Alliance Meeting; Lecture National Diabetes Alliance Meeting; Lecture National Diabetes Alliance Meeting (2009)
  • "Vascular Biology Working Group lecture" (2009)
  • "Macronutrients and Inflammation" (2008)
  • "Type 2 diabetes" European Symposium; European Symposium (2008)
  • "Diabetes and Vascular disease" (2008)
  • "Lecture on insulin and the heart" (2008)
  • "the anti-inflammatory and cardio-protective effects of insulin" (2008)
  • "insulin and its anti-inflammatory effects" ; American College of Cardiology; American College of Cardiology (2008)
  • "hypogonadotrophic hypogonadism in diabetes" (2007)
  • "lecture on oxidative stress, inflammation following macronutrient intake" (2007)
  • "Lectures on diabetes, inflammation and vascular disease Macronutrients and inflammation" (2007)
  • "A-Lecture to Vascular Biology Working Group" ; merican College of Cardiology; Vascular Biology Working Group (2007)
  • "Metabolic Syndrome" Annual Conference; Diabetes Association (2003)
  • "Metabolic Syndrome" Annual Meeting; ; Diabetes Association (2003)
  • "Metabolic Syndrome" Annual meeting; Postgraduate Medicine Symposium (2003)
  • "Metabolic Syndrome" National Meeting (2002)
  • "Insulin Resistance & Thiazolidenidiones" Consensus Meeting (2002)
  • "Metabolic Syndrome" Consensus Meeting; ; American College of Endocrinology (2002)
  • "Metabolic Syndrome" International Diabetes Federation (2002)
  • "Hydrocortisone inhibits the pro-inflammatory transcription factor, activator protein-1 (AP-1) & matrix metalloproteinases & 9 (MMP-2 & MMP-9)" Annual meeting; Endocrine Society (2001)
  • "Insulin inhibits the pro-inflammatory transcription factor early growth response-1 (Egr-1) in mononuclear cells & reduces plasma tissue factor & plasminogen activator inhibitor-1 concentrtions" Annual meeting; Endocrine Society (2001)
  • "Insulin reduces the pro-inflammatory transcription factor, activation protein-1 (AP-1) in mononuclear cells & plasma matrix metalloproteinase-9 concentration" Annual meeting; Endocrine Society (2001)
  • "Insulin reduces the pro-inflammatory transcription factor, activation protein-1 (AP-1), in mononuclear cells & plasma matrix metalloproteinase-9 concentration" Annual Meeting; American Diabetes Association (2001)
  • "Insuling inhibits the pro-inflammatory transcription factor erly growth response-1 (Egr-1) expression in mononuclear cells & reduces plasma tissue factor & plasminogen activator inhibitor-1 concentrations" Annual meeting; American Diabetes Association (2001)
  • "Rosiglitazone improves vascular reactivity, inhibits reactive oxygen species (ROS) generation, reduces p47phox subunit expression in mononuclear ells: Evidence of a potent anti-inflammatory effect" Annual meeting; Endocrine Society (2001)
  • "Rosiglitazone improves vascular reactivity, inhibits reactive oxygen species (ROS) generation, reduces p47phox subunit expression in mononucler cells (MNC): Evidence of a potent anti-inflammatory effect" Annual meeting; American Diabetes Association (2001)
  • "Troglitazone reduces intranuclear activator protein (AP-1) in mononuclear cells & plasma matrix metalloproteinase-9 concentration" Annual meeting; American Diabetes Association (2001)
  • "Troglitazone reduces intranuclear activator protein (AP-1) in mononuclear cells & plasma matrix metalloproteinase-9 concentration" Annual meeting; Endocrine Society (2001)
  • "Insulin inhibits intranuclear NFkB and stimulates IkB in mononucler cells in obese subjects: Evidence for an anti-inflammatory effect?" Workshop; 1st International Workshop on Insulin Resistance (2001)
  • "Rosiglitazone improves vascular reactivity, inhibits reactive oxygen species (ROS) generation, reduces p47phox subunit expressionin mononuclear cells: Evidence of a potent anti-inflammatory effect" Workshop; ; 1st International Workshop on Insulin Resistance (2001)
  • "Troglitazone inhibits mononuclear cell reactive oxygen species generation, NFkB & plasma pro-inflammatory factors in obese subjects: Evidence for an anti-inflammatory and anti-atherosclerotic effect" Workshop; 1st International Workshop on Insulin Resistance (2001)
  • "Troglitazone reduces the expression of PPARy while stimulating that of PPARa in mononuclear cells in obese subjects" Workshop; 1st International Workshop on Insulin Resistance (2001)
  • "Activation of signal transduction in the retina by lipid hydroperoxide" Meeting; The Association for Research in Vision and Opthalmology (2001)
  • "Insulin as an atherogenic hormone" Scientific Session; ; American Diabetes Association (2001)
  • "Metabolic Syndrome" ; ; Tulane & Louisiana State Universities (2001)
  • "MetabolicSyndrome" Conference; American Association of Clinical Endocrinologists; Baylor Medical Center (2001)
  • "HRT-Cardiovascular relationships" ; Albany Medical College; OB/GYN Department (1997)
  • "Maternal-fetal relationshps of calcium, vit.D & parthyroid hormone" ; All India Congress of Perinatology & Reproductive Biology; All India Congress (1997)
  • "Modern Treatment of Type II diabetes" Workshop; ; Physicians from Poland (1997)
  • "Pathogenesis & Management of Cardiovascular Disease in Diabetes" Diabetes Update; Univ. of Arkansas for Medical Sciences (1997)
  • "Physiology of obesity & weight loss" city-wide grand rounds; SUNY @ Buffalo; OB/GYN Dept. (1997)
  • "Treatment of insulin-resistance syndrome" Worskshop; ; Physicians from Turkey (1997)
  • "Abnormalities in vascular reactivity in diabetes mellitus" City-wide endocrine rounds; University of Toronto; Banting & Best Diabetes Centre (1996)
  • "Insulin-resistance, diabetes & obesity" ; Washinton Univ./24th Annual Diabetes Symposium; St. Louis Education Center (1996)
  • "Obesity management" ; Rochester Psychiatric Society (1996)
  • "Update in the treatment of diabetes mellitus" CME; Buffalo General Hospital (1996)
  • "Initiating & managing insulin treatment" Grand Rounds; SUNY @ Buffalo; Dept. of Family Medicine (1996)
  • "Pathophysiology of type 2 diabetes" 11th Annual Conference; ; Hypertension in Blacks (1996)
  • "Obesity management" Grand Rounds; Millard Fillmore Hospital (1996)
  • "Update on treatment options in type 2 diabetes mellitus" ; Mercy Hospital; Grand Rounds (1996)
  • "Clinical studies on soluble adhesion molecules" IBC‘s Conference on Cell Adhesion Molecules & Matrix Proteins (1996)
  • "Diabetes mellitus & its complications" Meeting; NYS, Office of Disability Determinations; Dept. of Social Services (1996)
  • "Free radicals and atherosclerosis" Meeting; Merck Frosst Canada; Medical Advisory Council (1996)
  • "Comprehensive treatment of diabetes" Grand Rounds; Millard Fillmore Hospital; Dept. of Medicine (1996)
  • "Lipids" Grand rounds; Albany Memorial Hospital (1996)
  • "Modern guidelines for diabetic care" ; Niagara Falls Memorial Medical Center (1996)
  • "Cardiovascular disease and menopause" HRT Symposium; Blue Cross/Blue Shield (1996)
  • "Exploring the clinical issues in diabetes/endocrinology training" ; St.Louis Univ & Bayer Corporation (1996)
  • "New treatment options for type 2 diabetes mellitus" ; Niagara Society of Family Physicians (1996)
  • "Recent studies on insulin as a vasodilator" Seminar; SUNY @ Buffalo; Cardiopulmonary Dept. (1996)
  • "Update on treatment options in type 2 diabetes mellitus" ; Cattaraugus County Medical Society (1996)
  • "alk at European Association for the Study of Diabetes Conference" ; European Association
See all (84 more)

Service Activities:

  • Committee Member Buswell Fellowship Committee; Member (1996–1998)
  • Member American Diabetes Association, New York State Affiliate; Board of Directors (1995–1996)
  • Founder & Coordinator Diabetci Patients' Forum (1995–present)
  • Committee member Harrington Committee. This committee is responsible for the selection of the most distinguished speakers to be invited to the Universitys' Lecture Series.; Committee Member (1993–1995)
  • Coordinator University Endocrinology Journal Club (1993–present)
  • Member, Steering Committee Cardiovascular Research Group. SUNY @ Buffalo; Member (1992–1994)
  • Coordinator Coordinator, Interdisciplinary Vascular & Metabolic Research Group (1991–present)
  • Founder and Coordinator Osteoporosis Bone Club
  • Board member Roswell Park Cancer Institute Brain Tumor Board; Board Member
  • Committee Member Millard Fillmore Hospital Medical Advisory Committee Member; Committee Member
  • Editor-in-Chief; Editor

School News:

In the Media:


Clinical Specialties:

Clinical Offices:

Insurance Accepted:



Contact Information

1020 Youngs Road
Williamsville, New York 14221
Phone: (716) 961-9900
Fax: (716) 961-9911
dandona@buffalo.edu

This faculty member is affiliated with UBMD, practicing physicians who are also professors in the Jacobs School.

View this physician on UBMD